Peter R Schofield Selected Research

CMP- N- acetylneuraminate- poly- alpha- 2,8- sialosyl sialyltransferase

1/2018	Differential effect of disease-associated ST8SIA2 haplotype on cerebral white matter diffusion properties in schizophrenia and healthy controls.
1/2014	Characterisation of genetic variation in ST8SIA2 and its interaction region in NCAM1 in patients with bipolar disorder.
1/2012	Identification of sialyltransferase 8B as a generalized susceptibility gene for psychotic and mood disorders on chromosome 15q25-26.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter R Schofield Research Topics

Disease

41	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 04/2002
24	Bipolar Disorder (Manic Depressive Psychosis) 07/2022 - 01/2002
13	Schizophrenia (Dementia Praecox) 07/2022 - 08/2008
11	Atrophy 01/2022 - 03/2006
10	Cognitive Dysfunction 01/2022 - 01/2002
8	Mental Disorders (Mental Disorder) 01/2021 - 04/2009
7	Disease Progression 04/2022 - 01/2013
7	Dementia (Dementias) 01/2022 - 01/2002
5	Genetic Risk Score 07/2022 - 01/2019
5	Mood Disorders (Mood Disorder) 01/2021 - 10/2009
4	Cerebral Cortical Thinning 01/2020 - 11/2013
4	Hypertension (High Blood Pressure) 01/2019 - 09/2002
3	Frontotemporal Dementia (Semantic Dementia) 01/2020 - 11/2006
3	Stroke (Strokes) 01/2019 - 09/2002
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 01/2013
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 11/2010 - 10/2007
2	Inflammation (Inflammations) 04/2022 - 01/2018
2	Amyloidosis 10/2018 - 09/2015
2	Psychotic Disorders (Schizoaffective Disorder) 05/2016 - 05/2013
2	Autistic Disorder (Autism) 01/2014 - 01/2012
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 06/2013 - 06/2010
2	Motor Neuron Disease (Primary Lateral Sclerosis) 11/2010 - 08/2008
1	App-Related Cerebroarterial Amyloidosis 03/2021
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 03/2021
1	Trisomy (Trisomies) 01/2021
1	Down Syndrome (Down's Syndrome) 01/2021
1	Gliosis 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Infarction (Infarctions) 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Neuralgia (Stump Neuralgia) 01/2017
1	Anxiety Disorders (Anxiety Disorder) 12/2014
1	Ischemic Stroke 01/2014

Drug/Important Bio-Agent (IBA)

28	Amyloid (Amyloid Fibrils)IBA 10/2022 - 01/2005
25	Biomarkers (Surrogate Marker)IBA 10/2022 - 08/2012
13	LithiumIBA 07/2022 - 04/2008
8	Presenilin-1IBA 11/2015 - 04/2002
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2003
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 04/2009
5	Biological ProductsIBA 01/2021 - 09/2005
4	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2002
4	DNA (Deoxyribonucleic Acid)IBA 06/2013 - 08/2008
3	Pharmaceutical PreparationsIBA 01/2021 - 06/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 11/2013
3	CMP- N- acetylneuraminate- poly- alpha- 2,8- sialosyl sialyltransferaseIBA 01/2018 - 01/2012
3	EnzymesIBA 01/2018 - 09/2002
3	UbiquitinIBA 08/2008 - 11/2006
3	Glycine Receptors (Glycine Receptor)IBA 05/2006 - 01/2002
2	Threonine (L-Threonine)FDA Link 01/2022 - 01/2021
2	Amyloid beta-PeptidesIBA 03/2021 - 01/2021
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 11/2013
2	tau Proteins (tau Protein)IBA 01/2020 - 08/2012
2	CholesterolIBA 01/2019 - 10/2011
2	Transcription Factors (Transcription Factor)IBA 12/2018 - 01/2012
2	MicroRNAs (MicroRNA)IBA 01/2018 - 05/2013
2	CalciumIBA 01/2017 - 02/2013
2	Glutamic Acid (Glutamate)FDA Link 01/2017 - 09/2002
2	Glycogen Synthase (Synthase I)IBA 01/2013 - 10/2008
2	DNA-Binding Proteins (DNA Binding Protein)IBA 11/2010 - 10/2007
2	Serotonin (5 Hydroxytryptamine)IBA 08/2010 - 10/2009
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 06/2010 - 11/2009
2	Antipsychotic Agents (Antipsychotics)IBA 12/2009 - 10/2008
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2008 - 03/2004
1	Circular RNAIBA 01/2022
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021
1	NeurocalcinIBA 01/2021
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2021
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2021
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021
1	FurinIBA 01/2021
1	AnkyrinsIBA 01/2021
1	Chitinase-3-Like Protein 1IBA 01/2021
1	Synaptosomal-Associated Protein 25IBA 01/2021
1	LipidsIBA 01/2019
1	AntigensIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	alpha-N-acetylneuraminate alpha-2,8-sialyltransferaseIBA 01/2018
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2017
1	Raloxifene Hydrochloride (Evista)FDA Link 12/2016
1	Selective Estrogen Receptor Modulators (SERM)IBA 12/2016
1	Estrogen ReceptorsIBA 12/2016
1	Estrogen Receptor alphaIBA 12/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2016
1	Indicators and Reagents (Reagents)IBA 09/2015
1	Oxytocin (Pitocin)FDA LinkGeneric 12/2014
1	sortilinIBA 01/2014
1	Type 1 Angiotensin ReceptorIBA 01/2014
1	polysialyl neural cell adhesion moleculeIBA 01/2014
1	Deoxyglucose (2 Deoxy D glucose)IBA 11/2013
1	Flavin-Adenine Dinucleotide (FAD)IBA 10/2013
1	Progesterone FDA LinkGeneric 09/2013
1	valylvaline (Val-Val)IBA 06/2013
1	Clozapine (Clozaril)FDA LinkGeneric 05/2013

Therapy/Procedure

4	Therapeutics 11/2021 - 11/2011
1	Polypharmacy 01/2022
1	Drug Therapy (Chemotherapy) 12/2016